BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18213729)

  • 21. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of invasion depth in oral tongue squamous cell carcinoma.
    Tan WJ; Chia CS; Tan HK; Soo KC; Iyer NG
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(5):264-70. PubMed ID: 23128365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue.
    Keski-Säntti H; Atula T; Törnwall J; Koivunen P; Mäkitie A
    Oral Oncol; 2006 Jan; 42(1):96-101. PubMed ID: 16256414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
    Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
    Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma.
    Shaw RJ; Brown JS; Woolgar JA; Lowe D; Rogers SN; Vaughan ED
    Head Neck; 2004 Oct; 26(10):861-9. PubMed ID: 15390204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue.
    Matsuzaki H; Shima K; Muramatsu T; Ro Y; Hashimoto S; Shibahara T; Shimono M
    J Oral Pathol Med; 2007 Jan; 36(1):30-4. PubMed ID: 17181739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
    Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
    J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
    Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
    Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed.
    Chang AM; Kim SW; Duvvuri U; Johnson JT; Myers EN; Ferris RL; Gooding WE; Seethala RR; Chiosea SI
    Oral Oncol; 2013 Nov; 49(11):1077-82. PubMed ID: 23988568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
    Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
    Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt activation correlates with adverse outcome in tongue cancer.
    Massarelli E; Liu DD; Lee JJ; El-Naggar AK; Lo Muzio L; Staibano S; De Placido S; Myers JN; Papadimitrakopoulou VA
    Cancer; 2005 Dec; 104(11):2430-6. PubMed ID: 16245318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is microvascular density an independent prognostic factor in squamous cell carcinoma of the tongue?].
    Fernández MM; García-Rozado A; Parente PL
    Acta Otorrinolaringol Esp; 2007 Oct; 58(8):341-6. PubMed ID: 17949660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of inflammatory infiltrate, perineural invasion, and risk score can indicate concurrent metastasis in squamous cell carcinoma of the tongue.
    de Matos FR; Lima Ed; Queiroz LM; da Silveira EJ
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1703-10. PubMed ID: 22154400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative analysis of anterior versus posterior squamous cell carcinoma of the tongue: a 10-year review.
    Mackle T; O'Dwyer T
    J Laryngol Otol; 2006 May; 120(5):393-6. PubMed ID: 16563198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
    Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers.
    Goto M; Hasegawa Y; Terada A; Hyodo I; Hanai N; Ijichi K; Yamada H; Fujimoto Y; Ogawa T
    Oral Oncol; 2005 Jan; 41(1):62-9. PubMed ID: 15598587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.
    Yanagawa T; Yoshida H; Yamagata K; Onizawa K; Tabuchi K; Koyama Y; Iwasa S; Shimoyamada H; Harada H; Omura K
    J Exp Clin Cancer Res; 2007 Jun; 26(2):215-20. PubMed ID: 17725101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary tumor thickness as a risk factor for contralateral cervical metastases in T1/T2 oral tongue squamous cell carcinoma.
    Bier-Laning CM; Durazo-Arvizu R; Muzaffar K; Petruzzelli GJ
    Laryngoscope; 2009 May; 119(5):883-8. PubMed ID: 19180635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.